Russian Heart Failure Journal 2010year Heart remodeling in secondary aortic valvular heart disease and after prosthetic


To access this material please log in or register

Register Authorize
2010/

Heart remodeling in secondary aortic valvular heart disease and after prosthetic

Varyasin V. V., Evdokimova A. G.

Keywords: secondary aortic valvular heart disease,  aortic valve prosthesis, heart remodeling

DOI: 10.18087/ rhfj.2010.3.1340

This review is about reverse development of LV hypertrophy in patients with aortic valvular disease after cardiac surgery.
  1. Pfeffer JM, Pfeffer MA, Mirsky I et al. Progressive ventricular dilatation and diastolic wall stress in rats with myocardial infarction and failure. Circulation. 1982;66 (Suppl II): II-66.
  2. Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res. 1985;57 (1):84–95.
  3. Weisman HF, Bush DE, Mannisi JA, Bulkley BH. Global cardiac remodeling after acutе myocardial infarction: a study in the rat model. J Am Coll Cardiol. 1985;5 (6):1355–1362.
  4. Jalil JE, Corbalán R. Post-infarct myocardial remodelling: from experimental data to the prevention of heart failure. Rev Med Chil. 1990;118 (10):1143–1149.
  5. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990;81 (4):1161–1172.
  6. Гуревич М. А. Журнал «Кардиоваскулярная терапия и профилактика» Особенности патогенеза и лечения сердечной недостаточности при дилатационной кардиомиопатии. Журнал Кардиоваскулярная терапия и профилактика. 2005;4 (1):83–89.
  7. Каленич О. Ремоделирование миокарда – основное звено в развитии недостаточности кровообращения при миокардитах. Российский кардиологический журнал. 1999;3:8–10.
  8. Sharpe N, Doghty RN. Left ventricular remodelling and improved longterm outcomes in chronic heart failure. Eur Heart J. 1998;19 Suppl B: B36–39.
  9. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol. 2000;35 (3):569–582.
  10. Беленков Ю. Н., Мареев В. Ю., Агеев Ф. Т. Что такое сердечная недостаточность? Как лучше ее диагностировать? Журнал Сердечная недостаточность. 2002;3 (5):209–210.
  11. Флоря В. Г. Роль ремоделирования левого желудочка в патогенезе хронической недостаточности кровообращения. Кардиология. 1997;47(5):63–69.
  12. Mihl C, Dassen WR, Kuipers H. Cardiac remodelling: concentric versus eccentric hypertrophy in strength and endurance athletes. Neth Heart J. 2008;16 (4):129–133.
  13. Ольбинская Л. И., Сизова Ж. М. Хроническая сердечная недостаточность. – М.: «Реафарм», 2001. – 344 с.
  14. Akki A, Seymour AM. Western diet impairs metabolic remodelling and contractile efficiency in cardiac hypertrophy. Cardiovasc Res. 2009;81(3):610–617.
  15. van Bilsen M, van Nieuwenhoven FA, van der Vusse GJ. Metabolic remodelling of the failing heart: beneficial or detrimental? Cardiovasc Res. 2009;81 (3):420–428.
  16. Vatta M, Stetson SJ, Perez-Verdia A et al. Molecular remodelling of dystrophin in patients with end-stage cardiomyopathies and reversal in patients on assistance-device therapy. Lancet. 2002;359 (9310):936–941.
  17. Yeghiazaryan K, Skowasch D, Bauriedel G et al. Could activated tissue remodeling be considered as early marker for progressive valve degeneration? Comparative analysis of checkpoint and ECM remodeling gene expression in native degenerating aortic valves and after bioprosthetic replacement. Amino Acids. 2007;32 (1):109–114.
  18. Dhalla NS, Saini-Chohan HK, Rodriguez-Leyva D et al. Subcellular remodelling may induce cardiac dysfunction in congestive heart failure. Cardiovasc Res. 2009;81 (3):429–438.
  19. Stockburger M, Nitardy A, Fateh-Moghadam S et al. Electrical remodeling and cardiac dimensions in patients treated by cardiac resynchronization and heart failure controls. Pacing Clin Electrophysiol. 2008;31 (1):70–77.
  20. Алшибая М. М., Коваленко О. А., Мусин Д. Е. и др Анатомо-физиологическое обоснование операции геометрической реконструкции левого желудочка с помощью эндоваскулярной заплаты при ишемической кардиомиопатии. В сборнике тезисов: Одиннадцатый всероссийский съезд сердечно-сосудистых хирургов. 23–26 октября 2005 г., Москва. – С. 86.
  21. Funder JA, Klaaborg KE, Egeblad H et al. Surgical left ventricle reconstruction for treatment of heart failure. Ugeskr Laeger. 2009;171 (15):1281–1285.
  22. Ueno T, Sakata R, Iguro Y et al. Left ventricular reconstruction with or without mitral annuloplasty. Ann Thorac Cardiovasc Surg. 2009;15 (3):165–170.
  23. Carabello BA. The relationship of left ventricular geometry and hypertrophy to left ventricular function in valvular heart disease. J Heart Valve Dis. 1995;4 Suppl 2:S132-138; discussion S138–139.
  24. Verma A, Meris A, Skali H et al. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study. JACC Cardiovasc Imaging. 2008;1 (5):582–591.
  25. Tovillas-Morán FJ, Zabaleta-Del-Olmo E, Dalfó-Baqué A et al. Cardiovascular Morbidity and Mortality and Left Ventricular Geometric Patterns in Hypertensive Patients Treated in Primary Care. Rev Esp Cardiol. 2009;62 (3):246–254.
  26. Baggish AL, Weiner RB, Yared K et al. Impact of family hypertension history on exercise-induced cardiac remodeling. Am J Cardiol. 2009;104 (1):101–106.
  27. Buchner S, Debl K, Haimerl J et al. Electrocardiographic diagnosis of left ventricular hypertrophy in aortic valve disease: evaluation of ECG criteria by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2009;11 (1):18.
  28. Carabello BA. Concentric versus eccentric remodeling. J Card Fail. 2002;8 (6 Suppl):S258–263.
  29. Eng C, Zhao M, Factor SM, Sonnenblick EH. Post-ischaemic cardiac dilatation and remodelling: reperfusion injury of the interstitium. Eur Heart J. 1993;14 (Suppl A):27–32.
  30. Васюк Ю. А., Козина А. А., Ющук Е. Н. с соавт. Особенности диастолической функции и ремоделирования левого желудочка у больных артериальной гипертензией и ишемической болезнью сердца. Журнал Сердечная недостаточность. 2003;4 (4):190–192.
  31. Морова Н. А., Федеров В. А. Динамика параметров левого желудочка после коррекции митрально-аортальных пороков сердца. Российский кардиологический журнал. 2003;3:29–32.
  32. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol. 2000;35 (3):569–582.
  33. Takano H, Hasegawa H, Nagai T, Komuro I. Implication of cardiac remodeling in heart failure: mechanisms and therapeutic strategies. Intern Med. 2003;42 (6):465–469.
  34. Tovillas-Morán FJ, Zabaleta-Del-Olmo E, Dalfó-Baqué A et al. Cardiovascular Morbidity and Mortality and Left Ventricular Geometric Patterns in Hypertensive Patients Treated in Primary Care. Rev Esp Cardiol. 2009;62 (3):246–254.
  35. Anversa P, Palackal T, Sonnenblick EH et al. Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ Res. 1990;67 (4):871–885.
  36. Abduch MC, Assad RS, Rodriguez MQ et al. Reversible pulmonary trunk banding III: assessment of myocardial adaptive mechanisms-contribution of cell proliferation. J Thorac Cardiovasc Surg. 2009;137 (6):1573.
  37. Саркисов Д. С., Пауков В. С. «Приспособительные и компенсаторные процессы». Патология: Руководство / под ред. Пальцева М. А., Паукова В. С., Уламбекова Э. Г. – М.:ГЭОТАР-МЕД.,2002. – 960 с.
  38. Iung B. Epidemiology of valvular heart diseases in the adult. Rev Prat. 2009;59 (2):173–177.
  39. Andrus BW, O’Rourke DJ. Percutaneous and surgical treatment of aortic stenosis. Expert Rev Cardiovasc Ther. 2006;4 (2):203–209.
  40. Abbas MI, Person DA. The Pacific Island Health Care Project (PIHCP): experience with rheumatic heart disease (RHD) from 1998 to 2006. Hawaii Med J. 2008;67 (12):326–329.
  41. Hillman ND, Tani LY, Veasy LG et al. Current status of surgery for rheumatic carditis in children. Ann Thorac Surg. 2004;78 (4):1403–1408.
  42. Митрофанова Л. Б ., Шляхто Е. В., Ковальский Г. Б. Ревматические пороки сердца и энтеровирусы. Российский кардиологический журнал. 2005;5:45–49.
  43. Akat K, Borggrefe M, Kaden JJ Aortic valve calcification: basic science to clinical practice. Heart. 2009;95 (8):616–623.
  44. Kaden JJ. Pathogenesis of calcific aortic valve stenosis. Herz. 2006 Oct; 31 (7):620–628.
  45. Aggeli C, Lampropoulos K, Stefanadis C. Aortic stenosis and hypertension: is there any relationship? Hellenic J Cardiol. 2009;50 (1):1–2.
  46. Hughes BR, Chahoud G, Mehta JL. Aortic stenosis: is it simply a degenerative process or an active atherosclerotic process? Clin Cardiol. 2005;28 (3):111–114.
  47. Spargias K, Manginas A, Pavlides G et al. Transcatheter aortic valve implantation: first Greek experience. Hellenic J Cardiol. 2008;49 (6):397–407.
  48. Varadarajan P, Kapoor N, Bansal RC, Pai RG. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg. 2006;82 (6):2111–2115.
  49. Pereira JJ, Lauer MS, Bashir M et al. Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. J Am Coll Cardiol. 2002;39 (8):1356–1363.
  50. Лекции по сердечно-сосудистой хирургии. Под ред. Л. А. Бокерия. В 2‑х т. Т. 1‑М.: Издательство НЦССХ им. А. Н. Бакулева РАМН. – 1999. – 348 с.
  51. Petrovic D. Cytopathological basis of heart failure--cardiomyocyte apoptosis, interstitial fibrosis and inflammatory cell response. Folia Biol (Praha). 2004;50 (2):58–62.
  52. Меерсон Ф. З. Миокард при гиперфункции, гипертрофии и недостаточности сердца. – М.: Медицина. 1965. – 320 с.
  53. Sabbah HN, Sharov VG, Goldstein S. Cell death, tissue hypoxia and the progression of heart failure. Heart Fail Rev. 2000;5 (2):131–138.
  54. Hein S, Arnon E, Kostin S et al. Progression from compensated hypertrophy to failure in the pressure-overload human heart. Structural deterioration and compensatory mechanisms. Circulation. 2003;107 (7):984–991.
  55. Mann DL, Bristow MR. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation. 2005;111 (21):2837–2849.
  56. Розенберг В. Д., Непомнящих Л. М. Патоморфологическая оценка кардиосклероза и ангиоархитектоники гипертрофированного миокарад- гипертензивного сердца. Бюл. экспер. биологии и медицины. 2004;137 (4):451–456.
  57. Luckie M, Irion L, Khattar RS. Severe mitral and aortic regurgitation in association with ankylosing spondylitis. Echocardiography. 2009;26 (6):705–710.
  58. Carrada-Bravo T. Cardiovascular syphilis: diagnosis, treatment. Arch Cardiol Mex. 2006;76 (Suppl 4):S189–196.
  59. Beckhauser AP, Vallin L, Burkievcz CJ et al. Valvular involvement in patients with rheumatoid arthritis. Acta Reumatol Port. 2009;34 (1):52–56.
  60. Svensson LG, Blackstone EH, Feng J et al. Are Marfan syndrome and marfanoid patients distinguishable on long-term follow-up? Ann Thorac Surg. 2007;83 (3):1067–1074.
Varyasin V. V., Evdokimova A. G. Heart remodeling in secondary aortic valvular heart disease and after prosthetic. Russian Heart Failure Journal. 2010;11(3):185-191.

To access this material please log in or register

Register Authorize
Ru En